Danish Research Center for Cancer Surgery | ACROBATIC
Research Collaboration Across Surgical Oncology for Better Patient Care
Clinical Focus Areas
ACROBATIC has three Clinical Focus Areas (CFAs) that are relevant across all 11 Danish Multidisciplinary Cancer Groups (DMCGs), covering prehabilitation, surgical innovation, and survivorship. All the projects (work packages) under ACROBATIC are covered by one or more of the CFAs.
Each CFA is headed by a leader, who is responsible for facilitating the initiation of national studies and trials through organization of CFA workshops and meetings, where knowledge sharing and collaboration across discipline and cancer type can flourish.
CFA1: Prehabilitation and preoperative risk assessment
- Increased and focused optimization before surgery
- Develop new algorithms for selecting the right patient for the right operation
Leader
Bente Thoft Jensen, PhD
Department of Urology, Aarhus University Hospital
Work Packages
WP 1.1: Multimodal Prehabilitation in Frail Colon Cancer Patients
WP leaders
Katrine J Emmertsen, MD, PhD, Department of Surgery, Regional Hospital Randers, Denmark
Ismail Gögenur, MD, DMSc, Professor, Centre for Surgical Science, Zealand University Hospital, Denmark
DMCG
Danish Colorectal Cancer Group
Participating institutions
Department of Surgery, Regional Hospital Randers
Dept. of Surgery, Zealand, Denmark University Hospital, Køge
Department of Surgery, Slagelse Hospital, Denmark
Department of Surgery, Viborg Regional Hospital, Denmark
Department of Surgery, Regional Hospital West Jutland, Herning, Denmark
Department of Surgery, Regional Hospital Horsens, Denmark
Department of Surgery, Vejle Hospital, part of Lillebaelt Hospital, Denmark
Department of Surgery, Aalborg University Hospital, Denmark
Department of Surgery, Aarhus University Hospital. Denmark
Department of Surgery, North Zealand Hospital Hillerød, Denmark
Department of Geriatrics at Aarhus University Hospital. Denmark
Steno Diabetes Center Aarhus, Aarhus University Hospital, Denmark
Danish Center for Health Economics, University of Southern Denmark, Denmark
Status: Incorporated into WP 1.7
WP 1.2: COMPETENCE - Perioperative Comprehensive Geriatric Assessment and tailored intervention in older, frail patients with muscle invasive bladder cancer scheduled for radical cystectomy
WP leader
Bente Thoft Jensen, Ph.D., Department of Urology, Aarhus University Hospital, Denmark
DMCG
Danish Bladder Cancer Group
Participating institutions
Department of Urology at all five University Hospitals performing radical cystectomies in Denmark:
Aalborg University Hospital
Aarhus University Hospital
Odense University Hospital
Copenhagen University Hospital, Rigshospitalet
Herlev University Hospital
Status: Recruiting
WP 1.3: FRAGINOC: The impact of FRAilty screening and Geriatric assessment and INtervention in older patients with epithelial Ovarian Cancer.
WP leader
Tine Henrichsen Schnack, associate professor, PhD, Department of Gynecology, Odense University Hospital, Denmark
DMCG
Danish Gynecologic Cancer Group
Participating institutions
Department of Gynecology, Odense University Hospital, Denmark
Department of Gynecology, Copenhagen University Hospital, Rigshospitalet, Denmark
Department of Gynecology, Roskilde University Hospital, Denmark
Department of Oncology, Odense University Hospital, Denmark
Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Denmark
Department of Oncology, Roskilde University Hospital, Denmark
Department of Oncology, Herlev University Hospital, Denmark
Department of Geriatric, Odense University Hospital, Denmark
Department of Geriatric, Herlev University Hospital, Denmark
Status: Recruiting
WP 1.4: RESTORE: Rehabilitative Exercise to elevate function for Surgical ineligible patienTs with nOn Small cell lung cancer to achieve possible cuRative surgEry.
WP leader
Morten Quist, Ph.D., PT., Rigshospitalet, Copenhagen University Hospital, Denmark
DMCG
Danish Lung Cancer Group
Participating institutions
Department of Cardio-Thoracic Surgery, Copenhagen University Hospital, Rigshospitalet, Denmark
Department of Cardio-Thoracic Surgery, Aalborg University Hospital, Denmark
Department of Cardio-Thoracic Surgery, Aarhus University Hospital, Denmark
Department of Cardio-Thoracic Surgery, Odense University Hospital, Denmark
Status: Expected start August 2024
WP 1.5: A randomized trial of enhanced recovery after radical prostatectomy
WP leader
Mads Hvid Aaberg Poulsen, consultant, associate professor, PhD, Department of Urology, Odense University Hospital, Denmark
DMCG
Danish Prostate Cancer Group
Participating institutions
Department of Urology, Odense University Hospital, Denmark
Department of Urology, Roskilde University Hospital, Denmark
Status: Pending
WP 1.7: AI-Driven Personalized Perioperative Management in Colorectal Cancer: A Randomized Controlled Clinical Trial - The AIDPRO-CRC trial
WP leader
Ismail Gögenur, MD, DMSc, Professor, Centre for Surgical Science, Zealand University Hospital
DMCGs
Danish Colorectal Cancer Group
Danish Renal Cancer Group
Danish Lung Cancer Group
Danish Gynecologic Cancer Group
Danish Prostate Cancer Group
Danish Bladder Cancer Group
Coordinating institution
Centre for Surgical Science, Zealand University Hospital, Denmark
Status: Recruiting
WP 1.8: The lived experience of physical prehabilitation among older women with advanced ovarian cancer and their families.
WP leader
Eva Jespersen, Ph.D, Associate professor, Department of Gynecology, Odense University Hospital and Svendborg Sygehus, Denmark
DMCGs
Danish Gynecological Cancer Group
Participating institutions
Department of Gynecology, Odense University Hospital, Denmark.
Department of Gynecology, Roskilde Hospital, Denmark.
Department of Gynecology, Herlev and Gentofte Hospital, Denmark
Department of Gynecology, Rigshospitalet, Denmark.
Status: Pending
CFA2: Surgical innovation and technique
- Developing of innovative methods to optimize the surgical techniques
- Establish a national surgical data collection system for robotic surgery
- Creation of a national platform for experimental cancer surgery
- Repurposing of novel surgical techniques and innovation across DMCGs derived from the cross- and inter-disciplinary collaboration
Leader
Thomas Baad-Hansen, MD, PhD
Professor, Consultant Orthopaedic Surgeon
Department of Othopaedic Surgery, Aarhus University Hospital, Denmark
Work Packages
WP 2.1: Surgical Data Vault - Improved surgical proficiency by linking robotic data to the operation
WP leader
Thiusius Rajeeth Savarimuthu M.Sc.Eng, PhD, Professor, Maersk Mc-Kinney Moller Institute, University of Southern Denmark, Denmark
DMCGs
All DMCGs performing robotic surgery
Participating institutions
Sub-specialities within each DMCG will be involved in a national data collection project
Status: Ongoing
WP 2.2: Quality of Life After primary TORS vs IMRT. "The QoLATI study” for patients with early-stage oropharyngeal squamous cell carcinoma: A Randomized National Trial
WP leader
Christian von Buchwald, Professor, DMSc, Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Denmark
DMCG
Danish Head and Neck Cancer Group
Participating institutions
Department of Otorhinolaryngology, Head and Neck Surgery, Rigshospitalet, Denmark
Department of Otorhinolaryngology, Head and Neck Surgery, Odense University Hospital, Denmark
Department of Otorhinolaryngology, Head and Neck Surgery, Aarhus University Hospital, Denmark
Status: Recruiting
WP 2.3: Economic Evaluation of Transoral Robotic Surgery versus Intensity Modulated Radiotherapy for Early Oropharyngeal Squamous Cell Carcinoma
WP leader
Thomas Kjærgaard, MD, PhD, Departmet of Otorhinolaryngology – Head & Neck Surgery, Aarhus University Hospital, Denmark
DMCG
Danish Head and Neck Cancer Group
Participating institutions
Department of Otorhinolaryngology, Head and Neck Surgery, Rigshospitalet, Denmark
Department of Otorhinolaryngology, Head and Neck Surgery, Odense University Hospital, Denmark
Status: Ongoing
WP 2.4: The Introduction of Salvage Robot-Assisted Radical Prostatectomy in Denmark
WP leaders
Mads Hvid Aaberg Poulsen, consultant, associate professor, Department for Urology, Odense University Hospital, Denmark
Michael Borre, Professor, Department of Urology Aarhus University Hospital, Denmark
DMCG
Danish Prostate Cancer Group
Participating institutions
Department of Urology, Odense University Hospital, Denmark
Depatment of Urology, Herlev Hospital, Denmark
Department of Urology, Aalborg University Hospital, Denmark
Status: Recruiting
WP 2.5: Better surgical palliation of patients with incurable cancer
WP leader
Hans Bjarke Rahr, MD DMSc, Professor, Deptartment of Surgery, part of Lillebaelt Hospital, Vejle Hospital, Denmark
DMCGs
TBA
Participating institutions
TBA
Status: TBA
WP 2.6: Palliative Pelvic Exenteration for Alleviating Symptoms in Cancer Patients
WP leader
Jonas Amstrup Funder, consultant, associate professor, PhD, Department of Surgery, Sygehus Lillebælt
DMCGs
Danish Colorectal Cancer Group
Danish Anal Cancer Group
Danish Gynecological Cancer Group
Danish Sarcoma Group
Participating institutions
Deptartment of Surgery, Aarhus University Hospital, Denmark
Department of Gynaecology, Aarhus University Hospital, Denmark
Danish Center for Health Economics (DaCHE), University of Southern Denmark
Department of Colorectal Surgery, St. Vincents University Hospital, Dublin.
Status: Pending
WP 2.8: SENTIVUC: Optic-guided Sentinel Node Mapping in patients with vulva cancer
WP leader
Ligita Paskeviciute Frøding, MD, Department of Gynecology, Copenhagen University Hospital, Rigshospitalet, Denmark
DMCG
Danish Gynecologic Cancer Group
Participating institutions
The two national centres for vulva cancer:
Department of Gynecology, Copenhagen University Hospital, Rigshospitalet, Denmark
Department of Gynecology, Aarhus University Hospital, Denmark
Status: Recruiting
WP 2.9: ICG-BREAST-LYMPH (IBL) - Breast cancer related lymphedema (BCRL) and breast reconstruction. An Inter-Regional Observational Study
WP leaders
Jens Ahm Sørensen MD, PhD, Professor, Consultant Plastic Surgeon, Department of Plastic Surgery, Odense University Hospital, Odense, Denmark
Tine Engberg Damsgaard MD, PhD, MRBS, Professor, Consultant Plastic Surgeon, Deptartment of Plastic Surgery, part of Lillebaelt Hospital, Vejle Hospital, Denmark
DMCG
Danish Breast Cancer Group
Participating institutions
Department of Plastic Surgery, Odense University Hospital, Odense, Denmark
Deptartment of Plastic Surgery, part of Lillebaelt Hospital, Vejle Hospital, Denmark
Status: Recruiting
WP 2.10: Reduction of positive margins and local recurrence in malignant musculoskeletal tumors – repurposing established technology for novel applications
WP leaders
Tine Engberg Damsgaard MD, PhD, MRBS, Professor, Consultant Plastic Surgeon, Department of Plastic Surgery, part of Lillebaelt Hospital, Vejle Hospital, Denmark
Thomas Baad-Hansen, Professor, Sarcoma division, Aarhus University Hospital, Aarhus, Denmark
DMCG
Danish Sarcoma Group
Participating institutions
Department of Orthopaedic Surgery (Section for Tumor Surgery), Aarhus University Hospital, Denmark
Department of Orthopaedic Surgery, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark
Department of Plastic Surgery, part of Lillebaelt Hospital, Vejle Hospital, Denmark
Status: Pending
WP 2.11: Improving sarcoma survival - implementing 3D print technology in complex sarcoma surgery
WP leader
Thomas Baad-Hansen, Professor, Sarcoma division, Aarhus University Hospital, Aarhus, Denmark
DMCG
Danish Sarcoma Group
Participating institutions
Sarcoma division, Aarhus University Hospital, Denmark
Sarcoma division, Rigshospitalet, Copenhagen, Denmark
Status: Ongoing
WP 2.12: Breast Cancer: 3D-printing of tumors and planning of breast conserving surgery
WP leader
Marianne Djernes Lautrup, consultant, associate professor, PhD, Department of Plastic and Breast Surgery, Aarhus University Hospital, Denmark
DMCG
Danish Breast Cancer Group
Participating institution
Deptartment of Plastic and Breast Surgery, Aarhus University Hospital, Denmark
Status: Inactive
WP 2.13: DBCG RT RECON trial: Delayed-immediate versus delayed breast reconstruction in early breast cancer patients treated with mastectomy and adjuvant loco-regional radiation therapy: A multicenter randomized clinical trial
WP leader
Tove Filtenborg Tvedskov, PhD, DMSc, consultant, associate professor, Deptartment of Breast Surgery, Herlev/Gentofte Hospital and Rigshospitalet, Denmark
DMCG
Danish Breast Cancer Group
Participating institutions
Deptartment of Breast Surgery, Herlev/Gentofte Hospital and Rigshospitalet, Denmark
Department of Plastic Surgery, Copenhagen University Hospital, Denmark
Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
Department of Plastic and Breast Surgery, Aarhus University Hospital, Denmark
Status: Recruiting
WP 2.14: Planning of surgery in the breast after NACT - how much to excise?
WP leaders
Tove Filtenborg Tvedskov, consultant, DMSc, PhD, associate professor, Department of Breast Surgery, Herlev/Gentofte Hospital and Rigshospitalet, Denmark
Ilse Vejborg, consultant, Department of Breast radiology, Rigshospitalet, Denmark
DMCG
Danish Breast Cancer Group
Participating institutions
Department of Breast Surgery, Herlev/Gentofte Hospital, Denmark
Department of Breast Surgery, Rigshospitalet, Denmark
Department of Breast radiology, Herlev-Gentofte Hospital, Denmark
Department of Breast radiology, Rigshospitalet, Denmark
Status: Pending
WP 2.15: Non-Invasive Diagnostics of Small Renal Masses (NISar)
WP leader
Lars Lund, Chair of DaRenCa, Professor and head of research, DmSci, FCS (HK), Department of Urology, Odense University hospital and University of Southern Denmark
DMCG
Danish Renal Cancer Group
Participating institutions
Department of Urology at Odense University Hospital, Denmark
Department of Urology at Roskilde University Hospital, Denmark
Department of Urology, Aalborg University Hospital, Denmark
Department of Urology, Vejle Hospital, Denmark
Department of Urology, Southwest Jutland Hospital, Denmark
Peter Clark, Professor, Chair of Department of Urology, Levine Cancer Institute, NC, USA
Maher Albitar, Director, Genomic Testing Cooperative, LCA.,Irvine, CA, USA
Status: Pending
WP 2.16: Peri-operative treatment with tranexamic acid (TXA); prognostic and treatment related impact of the plasmin(ogen) pathway in melanoma
WP leader
Marie Louise Bønnelykke-Behrndtz, Department Plastic- and Reconstructive Surgery, Aarhus University Hospital and Aalborg University Hospital, Denmark
DMCG
Danish Melanoma Group
Participating institutions
National collaboration from all Danish melanoma centers
Status: Recruiting
WP 2.17: Applying robot-guided laser osteotomies in malignant bone tumor resection and introducing interlocking osteotomies
WP leader
Thomas Baad-Hansen MD, PhD, Department of Orthopedic oncology, Aarhus University Hospital, Denmark
DMCG
Danish Sarcoma Group
Participating institutions
Department of Orthopedic oncology, Rigshospitalet, Copenhagen, Denmark
Department of Dentistry and Oral Health, Aarhus University, Denmark
Department of Orthopedic oncology, Aarhus University Hospital, Denmark
Status: Ongoing
WP 2.18: Towards preventing reoperations in breast cancer patients with intraoperative surgical margin assessment using spectral microCT
WP leaders
Trine Tramm, Department of Pathology Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Denmark
Jasper Nijkamp, Department of Oncology, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Denmark
DMCG
Danish Breast Cancer Group
Participating institutions
Department of Pathology Aarhus University Hospital, Denmark
Department of Oncology, Aarhus University Hospital, Denmark
Status: Ongoing
WP 2.19: Oncologic Events After Subcutaneous Mastectomy With Or Without Conservation Of The Nipple-areola Complex
WP leader
Tove Tvedskov, Department of Breast Surgery, Copenhagen University Hospital (Herlev/Gentofte Hospital and Rigshospitalet), Denmark
DMCG
Danish Breast Cancer Group
Participating institutions
Department of Breast Surgery, Copenhagen University Hospital (Herlev/Gentofte Hospital and Rigshospitalet), Denmark
Status: Ongoing
WP 2.20: BARREN
WP leader
Nadja Albertsen, MD, Ph.D., Department of Urology, Aarhus University Hospital, Denmark
DMCG
Danish Bladder Cancer Group
Participating institutions
Department of Urology, Herlev and Gentofte Hospital, Denmark
MidtSim, Aarhus University
Department of Urology, Rigshopitalet, Denmark
Department of Sports Science and Clinical Biomedchanics, University of Southern Denmark
Department of Surgery, Aarhus University Hospital, Denmark
Department of Gynecology and Obstetrics, Aarhus University Hospital
Status: Recruiting
WP 2.21: What is the effect of lymphovenous anastomoses in the treatment of lower limb lymphedema – a pragmatic, open label, randomized controlled trial
WP leader
Lisbet Rosenkrantz Hölmich, Department of Plastic Surgery, Herlev and Gentofte Hospital, Denmark
DMCG
Danish Lymphoma Group
Participating institutions
Department of Plastic Surgery, Roskilde Hospital and Academy for Medical Education and Simulation (CAMES), Denmark
Department of Plastic Surgery, Odense University Hospital
Department of Physiotherapy and Occupational Therapy, Herlev and Gentofte Hospital
Status: Pending
WP 2.22: Breast reconstruction; the multimodality approach
WP leader
Tine Engberg Damsgard, Department of Plastic Surgery, Vejle Denmark
DMCG
Danish Breast Cancer Group
Participating institutions
Department of Plastic Surgery, Vejle, Denmark.
Department og Plastic Surgery and Burns Treatment, Rigshospitalet, Denmark.
Status: Pending
WP 2.23: Intestinal anastomotic microirculation: a mattter of an objective approach
WP leader
Mai-Britt Worm Ørntoft, Department of Surgery, Gødstrup, Denmark.
DMCG
Danish Colon Cancer Cancer Group
Participating institutions
Department of Surgery, Gødstrup, Denmark.
Department of Clinical Medicine, Aarhus University, Denmark.
Department of Surgery, Vejle. Denmark.
Status: Pending
WP 2.24: A national longitudinal study of metastases-directed local ablative therapy for patients with oligometastatic disease - a combined interventional and observational trial (OLIGO-DK)
WP leader
Gitte Persson, Department of Oncology, Herlev and Gentofte Hospital, Denmark.
DMCG
All relevant DMCGs
Participating institutions
All medical and surgical cancer departments in Denmark.
Status: Active
CFA3: Survivorship
- Follow-up, late effects and life after cancer tailored to the patient’s preferences and needs, as well as digital solutions
- Creating models that address the patient’s needs in a digital patient pathway beyond cancer surgery with focus on quality of life and late effects
- Including patient reports outcome measures as key indicators and outcome parameters in research
Leader
Peter Christensen, MD, PhD
Professor
Danish Cancer Society National Research Center for survivorship and late adverse effects following pelvic organ cancer, Department of Surgery, Aarhus University Hospital, Denmark
Work Packages
WP 3.1: Patient-led follow-up with the use of digital solutions to increase self-management
WP leader
Therese Juul, Associate Professor, Department of Surgery, Aarhus University, Denmark
DMCGs
Danish Colorectal Cancer Group
Participating institutions
Department of Surgery, Aarhus University Hospital, Denmark
Department of Surgery, Regional Hospital West Jutland, Denmark
Department of Surgery, Aalborg University Hospital, Denmark
Department of Surgery, Vejle Hospital, part of Lillebaelt Hospital, Denmark
Status: Recruiting
WP 3.2: Key indicators for quality of life and late adverse effects following cancer treatment
WP leader
Peter Christensen, Professor, Danish Cancer Society National Research Center for survivorship and late adverse effect following pelvic organ cancer, Aarhus University Hospital, Denmark, and Department of Surgery, Aarhus University Hospital, Denmark
DMCGs
Danish Colorectal Cancer Group
Danish Breast Cancer Group
Danish Bladder Cancer Group
with potential migration into all DMCGs
Participating institutions
Danish Cancer Society National Research Center for survivorship and late adverse effect following pelvic organ cancer, Aalborg and Aarhus University Hospitals, Denmark
Danish Breast Cancer Group Center & Clinic for late effects (DCCL), Denmark
Deptartment of Oncology, Rigshospitalet, Denmark
Status: Ongoing
WP 3.3: Lost in technology? How to tailor follow-up and equal access to follow-up service
WP leader
Henriette Vind Thaysen, Clinical nurse specialist, Department of Surgery, Aarhus University Hospital, Denmark
DMCG
Danish Colorectal Cancer Group
Participating institutions
Department of Surgery, Aarhus University Hospital, Denmark
Department of Surgery, Regional Hospital West Jutland, Denmark
Department of Surgery, Aalborg University Hospital, Denmark
Department of Surgery, Danish Colorectal Cancer Centre South, Vejle Hospital, Denmark
Department of Cardio-Thoracic and Vascular Surgery, Aarhus University Hospital, Denmark
Danish Research Center for Equity in Cancer (COMPAS), Region Zealand, Denmark
Status: Recruiting
WP 3.4: Monitoring late adverse effect with Patient Reported Outcome Measures (ePROM) in patients operated for lung cancer data through an interactive mobile application
WP leader
Thomas Decker Christensen. Professor, Consultant, MD, DMSc, PhD., Department of Cardio-Thoracic and Vascular Surgery & Department of Clinical Medicine, Aarhus University Hospital, Denmark
DMCG
Danish Lung Cancer Group
Participating institutions
Department of Plastic and Breast Surgery, Aarhus University Hospital, Denmark
Department of Cardiothoracic Surgery, Copenhagen University Hospital, Rigshospitalet, Denmark
IT development, Central Denmark Region, Denmark
Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Denmark
Status: Pending
WP 3.5: The MELAcare study: a randomized controlled trial of a new method for surveillance of melanoma patients
WP leader
Lisbet Rosenkrantz Hölmich, Department of Plastic Surgery, Herlev and Gentofte Hospital, Denmark
DMCG
Danish Melanoma Group
Participating institutions
Department of Plastic Surgery, Herlev and Gentofte Hospital, Denmark
Psychological Aspects of Cancer, The Danish Cancer Society Research Center, Denmark
Department of Oncology, Rigshospitalet, Denmark
Danish Center for Health Economics, University of Southern Denmark, Denmark
Status: Data analysis
WP 3.6: Implementation of patient reported outcomes in melanoma treatment: Optimization of recognition and treatment of adverse effects in melanoma treatment
WP leader
Lisbet Rosenkrantz Hölmich, Dept. of Plastic Surgery, Herlev and Gentofte Hospital, Denmark
DMCG
Danish Melanoma Group
Participating institutions
Department of Plastic Surgery, Herlev and Gentofte Hospital, Denmark
Psychological Aspects of Cancer, The Danish Cancer Society Research Center, Denmark
The Danish Clinical Quality Program– National Clinical Registries (RKKP), Frederiksberg Hospital, Denmark
Status: Pending
WP 3.7: CONQUER: Late effects impact on Quality of Life after treatment for bladder cancer
WP leader
Jørgen Bjerggaard Jensen, Professor, DMSc, MD, Department of Urology, Aarhus University Hospital, Denmark
DMCG
Danish Bladder Cancer Group
Participating institutions
Department of Urology, Aarhus University Hospital, Denmark
Department of Surgery, Aarhus University Hospital, Denmark
Department of Oncology, Rigshospitalet, Denmark
Status: Data analysis
WP 3.8: DaVulvaRec: Danish Vulva Cancer Recurrence Study
WP leader
Pernille T. Jensen, Professor, Department Gynecology, Aarhus University Hospital and Aarhus University, Denmark
DMCG
Danish Gynaecological Cancer Group
Participating institutions
Department of Gynecology, Aarhus University Hospital, Denmark
Department of Gynecology, Rigshospitalet, Denmark
Department of Pathology, Aarhus University Hospital, Denmark
Department of Molecular Medicine, Aarhus University, Denmark
Status: Recruiting
WP 3.9: Can a biomarker-based follow-up regimen improve quality of life in patients with stage I and low-risk stage II colorectal cancer compared to standard follow-up?
WP leader
Ole Thorlacius Ussing, Professor, Dept. of Surgery, Aalborg University Hospital, Denmark
DMCG
Danish Colorectal Cancer Group
Participating institutions
This WP relies on the established framework of the IMPROVE-IT2 trial. Surgical centres at Aalborg, Hjørring, Herning, Viborg, Randers, Aarhus, Horsens, Odense, Svendborg, Herlev, Bispebjerg, Slagelse, and Køge are expected to participate.
ctDNA center and Department of Molecular Medicine, Aarhus University Hospital, Denmark
Regionernes Bio- and Genom Biobank, Denmark
Danish Center for Health Economics, University of Southern Denmark, Denmark
Status: Incorporated into WP 3.17
WP 3.10: A national prospective observational study of Circulating tumour DNA, exosomes and Quality of life in Sarcomas
WP leader
Ninna Aggerholm-Pedersen, Clinical Oncologist, MSc, PhD, associate professor, Sarcoma Center Aarhus University Hospital, Department of Oncology, Aarhus University Hospital, Denmark
DMCG
Danish Sarcoma Group
Participating institutions
Sarcoma center, Aarhus University Hospital, Denmark
Sarcoma Center, Herlev-Gentofte Hospital, Denmark
Department of Surgery, Aarhus University Hospital, Denmark
Department of Orthopedic surgery, Aarhus University Hospital, Denmark
Department of Orthopedic surgery, Rigshospitalet, Copenhagen, Denmark
Department of Oncology, Aarhus University Hospital, Denmark
Department of Oncology, Herlev-Gentofte Hospital, Denmark
Status: Recruiting
WP 3.11: Circulating tumor DNA for early detection of recurrence and risk-stratification in melanoma
WP leader
Lisbet Rosenkrantz Hölmich, Professor, DMSc, Department of Plastic Surgery, Herlev and Gentofte Hospital, Denmark
DMCG
Danish Melanoma Group
Participating institutions
Department of Plastic Surgery, Herlev and Gentofte Hospital, Denmark
Department of Plastic Surgery, Rigshospitalet, Denmark
Department of Plastic Surgery, Zealand University Hospital, Denmark
Department of Plastic Surgery, Aarhus University Hospital, Denmark
Status: Data analysis
WP 3.12: Venous thromboembolism in patients with primary lung cancer: Integrating information strategies to promote patient empowerment
WP leader
Thomas Decker Christensen. Professor, Consultant, MD, DMSc, PhD., Department of Cardio-Thoracic and Vascular Surgery & Department of Clinical Medicine, Aarhus University Hospital Denmark
DMCG
Danish Lung Cancer Group
Participating institutions
Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Department of Clinical Medicine, Aarhus University, Denmark
Danish Center for Health Services Research, Aalborg University & Aalborg University Hospital, Denmark
Department of Clinical Medicine, Aalborg University & Aalborg University Hospital, Denmark
Status: Recruiting
WP 3.13: Early Rehabilitation with a Vacuum Erectile Device in Patients Undergoing Nerve-sparing Robotic‑assisted Radical Prostatectomy A Randomized Trial
WP leader
Mads Hvid Aaberg Poulsen, consultant, associate professor, Department for Urology, Odense University Hospital, Denmark
DMCG
Danish Prostate Cancer Group
Participating institutions
Department for Urology, Odense University Hospital, Denmark
Department of Urology, Herlev/Gentofte Hopsital and Department of Clinical Medicine, University of Copenhagen, Denmark
Status: Pending
WP 3.14: CIRCPAC: Implementing non-invasive circulating tumor DNA and circular DNA analysis in patients with localized pancreatic cancer to optimize the pre- and postoperative treatment: predicting recurrence and survival and changing prognosis over time
WP leader
Claus Lindbjerg Andersen, Department of Molecular Medicine, Aarhus University Hospital, Denmark
DMCG
Danish Pancreatic Cancer Group
Participating institutions
Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Denmark
Department of Molecular Medicine, Aarhus University Hospital, Denmark
Department of Pathology, Odense University Hospital, Denmark
Department of Biology, University of Copenhagen, Denmark
Department of Surgery, Odense Pancreas Center (OPAC), Odense University Hospital, Denmark
Status: Recruiting
WP 3.15: Empowering breast cancer patients to assess and address their breast cosmetic outcome after breast conserving therapy
WP leader
Jasper Nijkamp, Department of Oncology, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Denmark
DMCG
Danish Breast Cancer Group
Participating institutions
Department of Plastic and Reconstructive Surgery, Odense University Hospital, Odense, and University Hospital of Southern Denmark, Vejle, Department of Regional Health Research, University of Southern Denmark, Denmark
Department of Experimental Clinical Oncology, Danish Centre for Particle Therapy, Department of Oncology, Aarhus University Hospital, Denmark
Dept. Oncology, Aarhus University Hospital and Department of Psychology and Behavioural Science, Aarhus University, Denmark
Software Engineering & Computing Systems Section at the Department of Electrical and Computer Engineering, Aarhus University, Aarhus, Denmark
Status: Ongoing
WP 3.17: RESPONSE: coloRectal cancEr Survivors’ follow-uP care – nOw digital and Need-baSEd. A national interventional trial for stage I and II patients
WP leader
Mai-Britt Worm Ørntoft, Department of Molecular Medicine, Aarhus University Hospital, Denmark, and Department of Surgery, Regional Hospital West Jutland, Denmark
DMCG
Danish Colorectal Cancer Group
Participating institutions
Department of Molecular Medicine, Aarhus University Hospital, Denmark
Department of Surgery, Aarhus University Hospital, Denmark
Department of Surgery, Regional Hospital West Jutland, Denmark
Department of Surgery, Aalborg University Hospital, Denmark
Department of Surgery, Vejle Hospital, part of Lillebaelt Hospital, Denmark
Danish Cancer Society National Research Center for survivorship and late adverse effect following pelvic organ cancer, Aarhus University Hospital, Denmark
ACROBATIC – Danish Research Center for Cancer Surgery
Status: Expected to start June 2024
Focus
Acrobatic Research